NCT06135415 2026-01-22
TirbAKare
Almirall, S.A.
Phase 3 Completed
Clinical Trials
5 trialsNCT05387525 2025-02-11
AKtive
Almirall, S.A.
Phase 4 Active not recruiting
NCT01397799 2015-12-07
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Athenex, Inc.
Phase 1 Completed
NCT01764087 2015-05-18
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors
Hanmi Pharmaceutical Company Limited
Phase 1/2 Unknown
NCT00658970 2011-06-08
Evaluation of KX2-391 in Patients With Advanced Malignancies
Athenex, Inc.
Phase 1 Completed